SANGAMO THERAPEUTICS INC shareholders Q3 2023

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.

SANGAMO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MACQUARIE GROUP LTD 400,000$240,0000.00%
Cambridge Investment Research Advisors, Inc. 30,854$190.00%
Citadel Advisors 64,500$38,6870.00%
Citadel Advisors 99,000$59,3800.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 850$10.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 69,463$41,6640.00%
GTS SECURITIES LLC 16,300$9,7800.00%
GTS SECURITIES LLC 22,792$13,6750.00%
Raymond James Financial Services Advisors, Inc. 25,632$15,3740.00%
Neuberger Berman Group LLC 14,281$8,5660.00%
HRT FINANCIAL LP 51,794$310.00%
Daiwa Securities Group Inc. 498$00.00%
SIMPLEX TRADING, LLC 39,485$230.00%
Steward Partners Investment Advisory, LLC 1,000$6000.00%
Qube Research & Technologies Ltd 5,705$3,4220.00%
Global Retirement Partners, LLC 490$2640.00%
Nuveen Asset Management, LLC 716,528$429,7740.00%
HighMark Wealth Management LLC 1,000$6000.00%
MetLife Investment Management, LLC 67,978$40,7730.00%
Tower Research Capital LLC (TRC) 13,421$8,0530.00%
External links

This page lists SANGAMO THERAPEUTICS INC's shareholders in Q3 2023. To view SANGAMO THERAPEUTICS INC's shareholder history, click here.